HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway

Kun Ma, Chuan Zhang

Open source

DOI
10.7150/jca.62787
Published
2022
Container
Journal of Cancer
Publisher
Ivyspring International Publisher
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7150/jca.62787,
  title = {HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway},
  author = {Kun Ma and Chuan Zhang},
  year = {2022},
  journal = {Journal of Cancer},
  doi = {10.7150/jca.62787},
  url = {https://doi.org/10.7150/jca.62787}
}

RIS

TY  - JOUR
TI  - HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway
AU  - Kun Ma
AU  - Chuan Zhang
PY  - 2022
JO  - Journal of Cancer
DO  - 10.7150/jca.62787
UR  - https://doi.org/10.7150/jca.62787
ER  - 

APA

Ma, K., & Zhang, C. (2022). HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway. Journal of Cancer. https://doi.org/10.7150/jca.62787

Source records